Results 161 to 170 of about 5,430 (178)

Daclatasvir

Reactions Weekly, 2017
openaire   +1 more source

Asunaprevir/daclatasvir

Reactions Weekly, 2020
openaire   +1 more source

Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)

Journal of Antimicrobial Chemotherapy, 2021
Sara Mobarak, Ahmad Hormati, Masood Ziaee   +2 more
exaly  

Asunaprevir/daclatasvir

Reactions Weekly, 2019
openaire   +2 more sources

Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late

Digestive and Liver Disease, 2014
Adriano M Pellicelli, Marzia Montalbano, Raffaella Lionetti   +2 more
exaly  

NS5A Sequence Heterogeneity and Mechanisms of Daclatasvir Resistance in Hepatitis C Virus Genotype 4 Infection

Journal of Infectious Diseases, 2016
Nannan Zhou, Dennis Hernández, Xiao Yang   +2 more
exaly  

Daclatasvir/sofosbuvir

Reactions Weekly, 2023
openaire   +2 more sources

Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma

Journal of Pharmaceutical and Biomedical Analysis, 2017
Giulio Nannetti, Lorenzo Messa, Marta Celegato   +2 more
exaly  

Daclatasvir/sofosbuvir

Reactions Weekly, 2022
openaire   +1 more source

Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients

Journal of Gastroenterology and Hepatology (Australia), 2016
Jōji Toyota, Yoshiyasu Karino, Yoshiiku Kawakami   +2 more
exaly